RA CAPITAL MANAGEMENT, L.P. received a stock award from ACRIVON THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 4/23/2026ACC: 0001231919-26-000396
Director10% Owner
Since Nov 2022
+3.89M
Net shares
Net buyer
$7.00M
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
3.89M acquired
Non-Derivative Transactions1
Common Stock
Indirect
Shares
+3.89M
Price / share
$1.80
Trade value
$7M
% of position
49.1%
4/22/2026
7.91M→11.80M
Total
Net shares
+3.89M
Net value
$7M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 4/22/2026 | A · Award | +3.89M | $1.80 | $7M | 49.1% | 7.91M | 11.80M |
| Total | +3.89M | $7M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned426.30K
Total
426.30K indirect426.30K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 426.30K | Indirect |
| Total | 426.30K | 426.30K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported